Perfil
Ms. Mira Leiwant is a Senior VP-Quality, Regulatory & Clinical Affairs at Anika Therapeutics, Inc. Ms. Leiwant was previously employed as a Vice President-Regulatory Affairs by BTG International, Inc. and a Senior Director-Regulatory & Quality Engineering by LifeCell Corp.
She received her undergraduate degree from Cornell University and a graduate degree from Cornell University.
Cargos activos de Mira Leiwant
| Empresas | Cargo | Inicio |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 14/10/2019 |
Antiguos cargos conocidos de Mira Leiwant.
| Empresas | Cargo | Fin |
|---|---|---|
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Consejero General | - |
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Corporate Officer/Principal | - |
Formación de Mira Leiwant.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Health Technology |
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Finance |
- Bolsa de valores
- Insiders
- Mira Leiwant
















